...
首页> 外文期刊>Journal of Translational Medicine >Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line
【24h】

Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum phthalocyanine photodynamic treatment in a human glioma cell line

机译:脱胶铝酞菁光动力处理在人胶质瘤细胞系中诱导克隆细胞存活的非单调变化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Photodynamic therapy (PDT) involves excitation of sensitizer molecules by visible light in the presence of molecular oxygen, thereby generating reactive oxygen species (ROS) through electron/energy transfer processes. The ROS, thus produced can cause damage to both the structure and the function of the cellular constituents resulting in cell death. Our preliminary investigations of dose-response relationships in a human glioma cell line (BMG-1) showed that disulphonated aluminum phthalocyanine (AlPcS2) photodynamically induced loss of cell survival in a concentration dependent manner up to 1 μM, further increases in AlPcS2concentration (>1 μM) were, however, observed to decrease the photodynamic toxicity. Considering the fact that for most photosensitizers only monotonic dose-response (survival) relationships have been reported, this result was unexpected. The present studies were, therefore, undertaken to further investigate the concentration dependent photodynamic effects of AlPcS2. Methods Concentration-dependent cellular uptake, sub-cellular localization, proliferation and photodynamic effects of AlPcS2 were investigated in BMG-1 cells by absorbance and fluorescence measurements, image analysis, cell counting and colony forming assays, flow cytometry and micronuclei formation respectively. Results The cellular uptake as a function of extra-cellular AlPcS2 concentrations was observed to be biphasic. AlPcS2 was distributed throughout the cytoplasm with intense fluorescence in the perinuclear regions at a concentration of 1 μM, while a weak diffuse fluorescence was observed at higher concentrations. A concentration-dependent decrease in cell proliferation with accumulation of cells in G2+M phase was observed after PDT. The response of clonogenic survival after AlPcS2-PDT was non-monotonic with respect to AlPcS2 concentration. Conclusions Based on the results we conclude that concentration-dependent changes in physico-chemical properties of sensitizer such as aggregation may influence intracellular transport and localization of photosensitizer. Consequent modifications in the photodynamic induction of lesions and their repair leading to different modes of cell death may contribute to the observed non-linear effects.
机译:背景技术光动力疗法(PDT)涉及在分子氧存在下通过可见光激发敏化剂分子,从而通过电子/能量转移过程产生活性氧物质(ROS)。由此产生的ROS可导致细胞成分的结构和功能受损,导致细胞死亡。我们对人胶质瘤细胞系(BMG-1)的剂量反应关系进行的初步研究表明,二磺化酞菁铝(AlPcS 2 )光动力学诱导细胞存活率的下降,其浓度依赖性最高可达1μM ,但观察到AlPcS 2 浓度(> 1μM)进一步增加会降低光动力毒性。考虑到大多数光敏剂仅报告了单调剂量-反应(生存)关系这一事实,这一结果是出乎意料的。因此,本研究旨在进一步研究AlPcS 2 的浓度依赖性光动力学效应。方法通过吸光度和荧光测量,图像分析,细胞计数和集落形成试验,血流分析法研究BMG-1细胞中AlPcS 2 的浓度依赖性细胞摄取,亚细胞定位,增殖和光动力效应。细胞计数和微核形成。结果观察到细胞摄取是细胞外AlPcS 2 浓度的函数,是双相的。 AlPcS 2 分布在整个细胞质中,在核周区域中浓度为1μM时具有强烈的荧光,而在浓度较高时则观察到微弱的扩散荧光。 PDT后,随着G 2 + M期细胞的积累,细胞增殖呈浓度依赖性降低。相对于AlPcS 2 浓度,AlPcS 2 -PDT后克隆形成存活的反应是非单调的。结论基于这些结果,我们得出结论,敏化剂理化性质的浓度依赖性变化(例如聚集)可能会影响光敏剂的细胞内转运和定位。病变的光动力诱导及其修复的相应修饰会导致细胞死亡的不同模式,可能有助于观察到的非线性效应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号